Skip to main content
Top
Gepubliceerd in:

01-11-2009

Determinants of global quality of life before and after major cancer surgery: an exploratory study

Auteurs: Martin Rutegård, Rachael Hughes, Pernilla Lagergren, Jane M. Blazeby

Gepubliceerd in: Quality of Life Research | Uitgave 9/2009

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Objective

To explore whether determinants of global quality of life (QOL) change before and after major cancer surgery.

Methods

Consecutive patients (n = 145) undergoing surgery for upper gastrointestinal cancer were prospectively studied and asked to complete the EORTC QLQ-C30 before and after 6 months. Excluded were patients found to be inoperable (n = 12) and those with missing second questionnaires (because of death n = 20, poor health (n = 10), administrative failure (n = 7) or patient refusal (n = 4)). Multivariable linear regression models investigated associations between global QOL and other scales and items of QOL adjusting for clinical variables.

Results

Some 87 patients completed both questionnaires. Before surgery the main predictors of global QOL were physical and emotional function, with adjusted increases in global QOL of 0.55 (95% CI 0.26–0.84; P < 0.001) and 0.30 (95% CI 0.14–0.45; P < 0.001) per unit increase of physical and emotional function, respectively. Six months after surgery, however, fatigue and dyspnea most strongly predicted global QOL, with adjusted differences in global QOL of −0.24 (95% CI −0.44 to −0.04; P = 0.02) per unit increase of fatigue and −6.28 (95% CI −12.64 to 0.07; P = 0.05) for those experiencing any symptoms of dyspnea.

Conclusion

Further work is needed to test these findings, but the results suggest that the global QOL scale in the QLQ-C30 is difficult to interpret and it should be considered within the context of other clinical and patient reported outcomes.
Literatuur
2.
go back to reference Goodwin, P. J., Black, J. T., Bordeleau, L. J., & Ganz, P. A. (2003). Health-related quality-of-life measurement in randomized clinical trials in breast cancer-taking stock. Journal of the National Cancer Institute, 95, 263–281.PubMedCrossRef Goodwin, P. J., Black, J. T., Bordeleau, L. J., & Ganz, P. A. (2003). Health-related quality-of-life measurement in randomized clinical trials in breast cancer-taking stock. Journal of the National Cancer Institute, 95, 263–281.PubMedCrossRef
3.
go back to reference Blazeby, J. M., Avery, K., Sprangers, M., Pikhart, H., Fayers, P., & Donovan, J. (2006). Health-related quality of life measurement in randomized clinical trials in surgical oncology. Journal of Clinical Oncology, 24, 3178–3186.PubMedCrossRef Blazeby, J. M., Avery, K., Sprangers, M., Pikhart, H., Fayers, P., & Donovan, J. (2006). Health-related quality of life measurement in randomized clinical trials in surgical oncology. Journal of Clinical Oncology, 24, 3178–3186.PubMedCrossRef
4.
go back to reference Bottomley, A., Efficace, F., Thomas, R., Vanvoorden, V., & Ahmedzai, S. H. (2003). Health-related quality of life in non-small-cell lung cancer: Methodologic issues in randomized controlled trials. Journal of Clinical Oncology, 21, 2982–2992.PubMedCrossRef Bottomley, A., Efficace, F., Thomas, R., Vanvoorden, V., & Ahmedzai, S. H. (2003). Health-related quality of life in non-small-cell lung cancer: Methodologic issues in randomized controlled trials. Journal of Clinical Oncology, 21, 2982–2992.PubMedCrossRef
5.
go back to reference Efficace, F., Kemmler, G., Vignetti, M., Mandelli, F., Molica, S., & Holzner, B. (2008). Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials—a systematic review to evaluate the added value in supporting clinical decision making. European Journal of Cancer, 44, 1497–1506.PubMedCrossRef Efficace, F., Kemmler, G., Vignetti, M., Mandelli, F., Molica, S., & Holzner, B. (2008). Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials—a systematic review to evaluate the added value in supporting clinical decision making. European Journal of Cancer, 44, 1497–1506.PubMedCrossRef
6.
go back to reference de Boer, A. G., van Lanschot, J. J., van Sandick, J. W., Hulscher, J. B., Stalmeier, P. F., de Haes, J. C., et al. (2004). Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. Journal of Clinical Oncology, 22, 4202–4208.PubMedCrossRef de Boer, A. G., van Lanschot, J. J., van Sandick, J. W., Hulscher, J. B., Stalmeier, P. F., de Haes, J. C., et al. (2004). Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. Journal of Clinical Oncology, 22, 4202–4208.PubMedCrossRef
7.
go back to reference Lagergren, P., Avery, K. N., Hughes, R., Barham, C. P., Alderson, D., Falk, S. J., et al. (2007). Health-related quality of life among patients cured by surgery for esophageal cancer. Cancer, 110, 686–693.PubMedCrossRef Lagergren, P., Avery, K. N., Hughes, R., Barham, C. P., Alderson, D., Falk, S. J., et al. (2007). Health-related quality of life among patients cured by surgery for esophageal cancer. Cancer, 110, 686–693.PubMedCrossRef
8.
go back to reference Blazeby, J. M., Metcalfe, C., Nicklin, J., Barham, C. P., Donovan, J., & Alderson, D. (2005). Association between quality of life scores and short-term outcome after surgery for cancer of the oesophagus or gastric cardia. The British Journal of Surgery, 92, 1502–1507.PubMedCrossRef Blazeby, J. M., Metcalfe, C., Nicklin, J., Barham, C. P., Donovan, J., & Alderson, D. (2005). Association between quality of life scores and short-term outcome after surgery for cancer of the oesophagus or gastric cardia. The British Journal of Surgery, 92, 1502–1507.PubMedCrossRef
9.
go back to reference Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365–376.PubMedCrossRef Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365–376.PubMedCrossRef
10.
go back to reference Fayers, P., Aaronson, N. K., Bjordal, K., Groenvold, M., Curran, D., & Bottomley, A. (2001) The EORTC QLQ-C30 scoring manual (3rd ed.). European Organisation for Research and Treatment of Cancer, Brussels. Fayers, P., Aaronson, N. K., Bjordal, K., Groenvold, M., Curran, D., & Bottomley, A. (2001) The EORTC QLQ-C30 scoring manual (3rd ed.). European Organisation for Research and Treatment of Cancer, Brussels.
11.
go back to reference Vacanti, C. J., VanHouten, R. J., & Hill, R. C. (1970). A statistical analysis of the relationship of physical status to postoperative mortality in 68, 388 cases. Anesthesia and Analgesia, 49, 564–566.PubMedCrossRef Vacanti, C. J., VanHouten, R. J., & Hill, R. C. (1970). A statistical analysis of the relationship of physical status to postoperative mortality in 68, 388 cases. Anesthesia and Analgesia, 49, 564–566.PubMedCrossRef
12.
go back to reference Arndt, V., Stegmaier, C., Ziegler, H., & Brenner, H. (2006). A population-based study of the impact of specific symptoms on quality of life in women with breast cancer 1 year after diagnosis. Cancer, 107, 2496–2503.PubMedCrossRef Arndt, V., Stegmaier, C., Ziegler, H., & Brenner, H. (2006). A population-based study of the impact of specific symptoms on quality of life in women with breast cancer 1 year after diagnosis. Cancer, 107, 2496–2503.PubMedCrossRef
13.
go back to reference Beijer, S., Kempen, G. I., Pijls-Johannesma, M. C., de Graeff, A., & Dagnelie, P. C. (2008). Determinants of overall quality of life in preterminal cancer patients. International Journal of Cancer, 123, 232–235.CrossRef Beijer, S., Kempen, G. I., Pijls-Johannesma, M. C., de Graeff, A., & Dagnelie, P. C. (2008). Determinants of overall quality of life in preterminal cancer patients. International Journal of Cancer, 123, 232–235.CrossRef
14.
go back to reference Dagnelie, P. C., Pijls-Johannesma, M. C., Lambin, P., Beijer, S., De Ruysscher, D., & Kempen, G. I. (2007). Impact of fatigue on overall quality of life in lung and breast cancer patients selected for high-dose radiotherapy. Annals of Oncology, 18, 940–944.PubMedCrossRef Dagnelie, P. C., Pijls-Johannesma, M. C., Lambin, P., Beijer, S., De Ruysscher, D., & Kempen, G. I. (2007). Impact of fatigue on overall quality of life in lung and breast cancer patients selected for high-dose radiotherapy. Annals of Oncology, 18, 940–944.PubMedCrossRef
15.
go back to reference Ostlund, U., Wennman-Larsen, A., Gustavsson, P., & Wengstrom, Y. (2007). What symptom and functional dimensions can be predictors for global ratings of overall quality of life in lung cancer patients? Supportive Care in Cancer, 15, 1199–1205.PubMedCrossRef Ostlund, U., Wennman-Larsen, A., Gustavsson, P., & Wengstrom, Y. (2007). What symptom and functional dimensions can be predictors for global ratings of overall quality of life in lung cancer patients? Supportive Care in Cancer, 15, 1199–1205.PubMedCrossRef
16.
go back to reference Moinpour, C. M., Donaldson, G. W., & Redman, M. W. (2007). Do general dimensions of quality of life add clinical value to symptom data? Journal of the National Cancer Institute Monogr, 31–38. Moinpour, C. M., Donaldson, G. W., & Redman, M. W. (2007). Do general dimensions of quality of life add clinical value to symptom data? Journal of the National Cancer Institute Monogr, 31–38.
17.
go back to reference Greene, F. L., & Sobin, L. H. (2002). The TNM system: Our language for cancer care. Journal of Surgical Oncology, 80, 119–120.PubMedCrossRef Greene, F. L., & Sobin, L. H. (2002). The TNM system: Our language for cancer care. Journal of Surgical Oncology, 80, 119–120.PubMedCrossRef
Metagegevens
Titel
Determinants of global quality of life before and after major cancer surgery: an exploratory study
Auteurs
Martin Rutegård
Rachael Hughes
Pernilla Lagergren
Jane M. Blazeby
Publicatiedatum
01-11-2009
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 9/2009
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-009-9534-7